ReviewCureus2026
Impact of Coronary Collaterals on Infarct Size and Left Ventricular Ejection Fraction After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many factors influence outcomes in patients with coronary artery disease (CAD) and acute myocardial infarction (AMI), including patient demographics, comorbidities, cardiac function, clinical presentation, and revascularization therapies. Percutaneous coronary intervention (PCI) is associated with reduced infarct size (IS) and improved left ventricular ejection fraction (LVEF), which have both been shown to reduce all-cause mortality and hospitalization for heart failure following AMI. Coronary collateral circulation may also have a protective effect in CAD and, like PCI, may play a role in limiting IS and improving LVEF after AMI. In this systematic review and meta-analysis, our objective was to investigate the impact of coronary collaterals on IS and LVEF after AMI. A search of Embase, Web of Science, and PubMed from 1980 onwards was conducted in July 2025 using the keywords "coronary collaterals", "myocardial infarction", and "infarct size." A total of six studies (n=820) were included for review, which compared IS and LVEF measured by cardiac magnetic resonance imaging (CMR) between patients with poor and good collaterals after undergoing PCI for AMI. Mean difference (MD) was calculated, and both the common effect and random effects models were conducted to pool effect sizes. IS was consistently larger in patients with poor collaterals. The random effects model gave a statistically significant pooled mean difference (MD) of 5.19 (95% CI = 0.99, 9.40, Z = 3.18, p = 0.024). Studies reported mixed results regarding LVEF, and the random effects model gave us a pooled MD -2.62 (95% CI = -5.36, 0.11, Z = -2.03, p = 0.056), which was not statistically significant. In conclusion, we found that in patients presenting with AMI, greater development of coronary collaterals is associated with a significant reduction in IS. Clinically, this finding is important as a smaller IS is associated with a reduction in long-term mortality and hospitalization for heart failure after AMI treated with primary PCI. We also found a trend toward improved LVEF in patients who experienced AMI with more extensive collaterals, although these results were not significant. Based on these results, the impact of coronary collaterals on IS rather than LVEF may be a more promising area of research for improving patient survival after AMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.